Government Bond Auction Results 6.68% GS 2040 and 7.43% GS 2076

The Reserve Bank of India published full auction results for two government stock tranches: ₹17,000 crore of 6.68% GS 2040 and ₹12,000 crore of 7.43% GS 2076. Both auctions achieved 99.92% and 99.88% of notified amounts respectively. The 6.68% GS 2040 attracted 240 competitive bids totaling ₹32,591.30 crore with a cut-off yield of 7.5303%, while the 7.43% GS 2076 received 120 bids worth ₹26,999 crore at a cut-off yield of 7.8812%.

Government Stock Auction Results: Cut-off Prices

The Reserve Bank of India conducted a government stock auction on April 2, 2026, successfully raising ₹29,000 crore through two tranches. The 6.68% GS 2040 tranche (₹17,000 crore) was accepted at a cut-off price of ₹92.63 (implicit yield 7.5303%), while the 7.43% GS 2076 tranche (₹12,000 crore) was accepted at a cut-off price of ₹94.38 (implicit yield 7.8812%). Devolvement on Primary Dealers was NIL for both tranches.

RBI Underwriting Auction Results Government Securities

The Reserve Bank of India announced results of an underwriting auction conducted on April 2, 2026, for Additional Competitive Underwriting of government securities totaling ₹29,000 crore. Two securities were underwritten: ₹17,000 crore of 6.68% GS 2040 and ₹12,000 crore of 7.43% GS 2076. Cut-off commission rates were set at 7.40 and 10.10 paise per ₹100 respectively.

HABIT-ILE Intervention Clinical Trial in Children with Cerebral Palsy

The National Library of Medicine registered Clinical Trial NCT07506837 on ClinicalTrials.gov, a study examining HABIT-ILE (Hand Arm Bimanual Intensive Training Including Lower Extremity) intervention effectiveness in children aged 3-8 with cerebral palsy. The trial aims to assess mobility, bimanual hand use, and motor function outcomes. The study is actively recruiting at a single US site with an estimated enrollment of 28 participants.

Russian Extreme Hypertriglyceridemia Registry

ClinicalTrials.gov registered a new observational study, NCT07508930, titled 'Russian Extreme Hypertriglyceridemia Registry'. The registry will collect data on patients with extreme hypertriglyceridemia in Russia. This is a prospective cohort study registered as an observational study documenting natural disease progression and patient outcomes.

Clinical trial on exercise for migraine relief

The National Library of Medicine registered clinical trial NCT07508449 on ClinicalTrials.gov, investigating exercise as an intervention for migraine relief. The trial represents standard clinical research registration with no new regulatory requirements. Healthcare providers and patients may consider trial participation.

Oral decitabine plus ivosidenib first line AML trial

The National Library of Medicine registered a new clinical trial (NCT07507760) on ClinicalTrials.gov investigating oral decitabine in combination with ivosidenib as a first-line treatment for acute myeloid leukemia (AML). The trial represents an evaluation of this drug combination in the specified therapeutic indication.

VV913 capsules pharmacokinetics safety trial healthy volunteers

NIH National Library of Medicine registered a new clinical trial NCT07507838 on ClinicalTrials.gov to evaluate the pharmacokinetics and safety of VV913 capsules in healthy volunteers. The trial is registered as an interventional study.

Exercise risk assessment for lung cancer lobectomy patients

The National Library of Medicine registered a new clinical study (NCT07506889) on ClinicalTrials.gov investigating exercise risk assessment for patients undergoing lung cancer lobectomy. The registry entry documents study parameters, eligibility criteria, and investigators for this observational study.

Vidal v. Venettozzi - Prison Disciplinary Due Process

The Second Circuit vacated summary judgment for DOCCS officials in Vidal v. Venettozzi, holding that Joseph Vidal's 270-day disciplinary segregation in the Special Housing Unit constitutes an atypical and significant hardship implicating a protected liberty interest under the Fourteenth Amendment. The court remanded for further proceedings on Vidal's procedural due process claims, including denial of witness testimony and documentary evidence at his disciplinary hearing.